Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 402 participants.
Also called NCT01456949
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 402 participants
- Registry
-
NCT01456949
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT01456949. Allocation not applicable; no masking; primary purpose treatment. Start 2012-06-26 (actual); primary completion 2017-11-30 (actual). Results posted on 2019-01-11.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)
- Acronym
- STOP AF PAS
- Condition
- Paroxysmal Atrial Fibrillation (PAF)
- Intervention (Device)
- Medtronic Arctic Front® Cardiac CryoAblation System
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
Record details
- Record id
cardio:ct-nct01456949- Content hash
2c5f84a5171851cd15c8873cbacee1d28b67428b7d1bd377ddab7317a6fb7038